UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9195

2022

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001657

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer

Cancers, 2022-01, Vol.14 (2), p.294

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy

Seminars in liver disease, 2018-11, Vol.38 (4), p.379

2018

Link zum Volltext

Verfügbarkeit prüfen

SN‐38, an active metabolite of irinotecan, enhances anti‐PD‐1 treatment efficacy in head and neck squamous cell carcinoma

The Journal of pathology, 2023-04, Vol.259 (4), p.428-440

2023

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13346

2021

Link zum Volltext

Verfügbarkeit prüfen

Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer

Journal of biomedical science, 2024-01, Vol.31 (1), p.1-1, Article 1

2024

Link zum Volltext

Verfügbarkeit prüfen

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

Liver cancer (Basel ), 2021-07, Vol.10 (4), p.346-359

2021

Link zum Volltext

Verfügbarkeit prüfen

Mouse Models for Immunotherapy in Hepatocellular Carcinoma

Cancers, 2019-11, Vol.11 (11), p.1800

2019

Link zum Volltext

Verfügbarkeit prüfen

Zebrafish as a disease model for studying human hepatocellular carcinoma

World journal of gastroenterology : WJG, 2015-11, Vol.21 (42), p.12042-12058

2015

Link zum Volltext

Verfügbarkeit prüfen

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Molecular oncology, 2019-04, Vol.13 (4), p.928-945

2019

Link zum Volltext

Verfügbarkeit prüfen

Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias

Cancer gene therapy, 2022-05, Vol.29 (5), p.519-532

2022

Link zum Volltext

Verfügbarkeit prüfen

Cytarabine-Resistant FLT3 -ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1230

2019

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells

PloS one, 2012-11, Vol.7 (11), p.e50701

2012

Link zum Volltext

Verfügbarkeit prüfen

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

Molecular cancer, 2014-01, Vol.13 (1), p.2-2, Article 2

2014

Link zum Volltext

Verfügbarkeit prüfen

PB1778: PAN‐PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI‐LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e6210037-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis

Biomedicines, 2021-12, Vol.9 (12), p.1869

2021

Link zum Volltext

Verfügbarkeit prüfen

PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN‐PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT‐DRIVEN T(8/21)

HemaSphere, 2023-08, Vol.7 (S3), p.e4377164-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

PloS one, 2013-06, Vol.8 (6), p.e66589

2013

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti‐PD1 in Liver Cancer

Advanced therapeutics, 2021-06, Vol.4 (6), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence

Electrophoresis, 2012-09, Vol.33 (17), p.2769-2776

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma

Liver cancer (Basel ), 2019-05, Vol.8 (3), p.155-171

2019

Link zum Volltext

Verfügbarkeit prüfen

Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma

Journal of gastroenterology and hepatology, 2014-12, Vol.29 (12), p.2021-2031

2014

Link zum Volltext

Verfügbarkeit prüfen

Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma

British journal of cancer, 2022-06, Vol.126 (12), p.1806-1814

2022

Link zum Volltext

Verfügbarkeit prüfen

A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies

Drug discovery today, 2024-03, Vol.29 (3), p.103893-103893, Article 103893

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(67)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(32)
Humans
(25)
Oncology
(22)
Animals
(16)
Cell Line, Tumor
(16)
Tumors
(13)
Kinases
(12)
Antineoplastic Agents - Pharmacology
(10)
Apoptosis
(10)
Mice
(10)
Proteins
(10)
Cancer
(9)
Cancer Therapies
(9)
Carcinoma, Hepatocellular - Metabolism
(9)
Hepatocellular Carcinoma
(9)
Apoptosis - Drug Effects
(8)
Carcinoma, Hepatocellular - Drug Therapy
(8)
Carcinoma, Hepatocellular - Pathology
(8)
Liver Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(6)
Blood
(4)
Cancer Gene Therapy
(3)
Clinical Cancer Research
(3)
International Journal Of Molecular Sciences
(3)
Molecular Cancer
(3)
Molecular Cancer Therapeutics
(3)
Annals Of Oncology
(2)
Cancers
(2)
Chemical Science
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer

Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy

SN‐38, an active metabolite of irinotecan, enhances anti‐PD‐1 treatment efficacy in head and neck squamous cell carcinoma

Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase

Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer

Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

Mouse Models for Immunotherapy in Hepatocellular Carcinoma

Zebrafish as a disease model for studying human hepatocellular carcinoma

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias

Cytarabine-Resistant FLT3 -ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

PB1778: PAN‐PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI‐LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA

Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis

PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN‐PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT‐DRIVEN T(8/21)

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti‐PD1 in Liver Cancer

Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence

Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma

Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma

Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma

A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies

Suchergebnisse filtern